Interactions in the postprandial appearance of β-carotene and canthaxanthin in plasma triacylglycerol-rich lipoproteins in humans

American Journal of Clinical Nutrition

Volumn 66, Issue 5, 1997, Pages 1133-1143

  Paetau, Inke ^a   Chen, Huiping ^a   Goh, Natalie M Y ^a   White, Wendy S ^a  

^a IOWA STATE UNIVERSITY   (United States)

Author keywords

Canthaxanthin; Carotenoids; Chy lomicrons; Humans; Interactions; Lipoproteins; Women; Carotene

Indexed keywords

BETA CAROTENE; CANTHAXANTHIN; CHYLOMICRON; INTERMEDIATE DENSITY LIPOPROTEIN; LIPOPROTEIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG DISTRIBUTION; FEMALE; HUMAN; INGESTION; LIPID COMPOSITION; LIPOPROTEIN BLOOD LEVEL; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; POSTPRANDIAL STATE;

EID: 0030836291     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/66.5.1133     Document Type: Article

References (51)

1. van Poppel G, Goldbohm RA. Epidemiologic evidence for β-carotene and cancer prevention. Am J Clin Nutr 1995;62(suppl):1393S-402S.
2. Ziegler RG, Mayne ST, Swanson CA. Nutrition and lung cancer. Cancer Causes Control 1996;7:157-77.
3. Albanes D, Heinonen OP, Taylor PR, et al. α-Tocopherol and β-carotene supplements and lung cancer incidence in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study: effects of baseline characteristics and study compliance. J Natl Cancer Inst 1996;88:1560-70.
4. Omenn GS, Goodman GE, Thornquist MD, et al. Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial. J Natl Cancer Inst 1996;88:1550-9.
5. Hennekens CH, Buring JE, Manson JE, et al. Lack of effect of long-term supplementation with β-carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 1996;334:1145-9.
6. Le Marchand L, Hankin JH, Bach F, et al. An ecological study of diet and lung cancer in the South Pacific. Int J Cancer 1995;63:18-23.
7. Swanson CA, Mao BL, Li JY, et al. Dietary determinants of lung-cancer risk: results from a case-control study in Yunnan Province, China. Int J Cancer 1992;50:876-80.
8. Seddon JM, Ajani UA, Sperduto RD, et al. Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. JAMA 1994;272:1413-20.
9. Bone RA, Landrum JT, Tarsis SL. Preliminary identification of the human macular pigment. Vision Res 1985;25:1531-5.
10. Handelman GJ, Dratz EA, Reay CC, van Kuijk FJGM. Carotenoids in the human macula and whole retina. Invest Ophthalmol Vis Sci 1988;29:850-5.
11. Schalch W. Carotenoids in the retina - a review of their possible role in preventing or limiting damage caused by light and oxygen. In: Emerit I, Chance B, eds. Free radicals and aging. Basel, Switzerland: Birkhäuser Verlag, 1992:280-98.
12. Krinsky NI, Cornwell DG, Oncley JL. The transport of vitamin A and carotenoids in human plasma. Arch Biochem Biophys 1958;73:233-46.
13. Clevidence BA, Bieri JG. Association of carotenoids with human plasma lipoproteins. Methods Enzymol 1993;214:33-46.
14. Ribaya-Mercado JD, Ordovas JM, Russell RM. Effect of β-carotene supplementation on the concentrations and distribution of carotenoids, vitamin E, vitamin A, and cholesterol in plasma lipoprotein and nonlipoprotein fractions in healthy older women. J Am Coll Nutr 1995;14:614-20.
15. Ockner RK, Hughes FB, Isselbacher KJ. Very low density lipoproteins in intestinal lymph: role in triglyceride and cholesterol transport during fat absorption. J Clin Invest 1969;48:2367-73.
16. Packard CJ, Munro A, Lorimer AR, Gotto AM, Shepherd J. Metabolism of apolipoprotein B in large triglyceride-rich very low density lipoproteins of normal and hypertriglyceridemic subjects. J Clin Invest 1984;74:2178-92.
17. Karpe F, Steiner G, Olivecrona T, Carlson LA, Hamsten A. Metabolism of triglyceride-rich lipoproteins during alimentary lipemia. J Clin Invest 1993;91:748-58.
18. Field FJ, Mathur SN. Intestinal lipoprotein synthesis and secretion. Prog Lipid Res 1995;34:185-98.
19. White WS, Stacewicz-Sapuntzakis M, Erdman JW Jr, Bowen PE. Pharmacokinetics of β-carotene and canthaxanthin after ingestion of individual and combined doses by human subjects. J Am Coll Nutr 1994;13:665-71.
20. Rifkind BM, Segal P. Lipid Research Clinics Program reference values for hyperlipidemia and hypolipidemia. JAMA 1983;250:1869-72.
21. Britton, G. Carotenoids. In: The biochemistry of natural pigments. Cambridge, United Kingdom: Cambridge University Press, 1983:23-73.
22. National Archives and Records Administration. Code of federal regulations. Washington, DC: US Government Printing Office, 1996. (21 CFR § 73.75 1996:305.)
23. Bauernfeind JC. Natural food colors. In: Bauernfeind JC, ed. Carotenoids as colorants and vitamin A precursors. New York: Academic Press, 1981:1-45.
24. Kostic D, White WS, Olson JA. Intestinal absorption, serum clearance, and interactions between lutein and β-carotene when administered to human adults in separate or combined oral doses. Am J Clin Nutr 1995;62:604-10.
25. Redgrave TG, Carlson LA. Changes in plasma very low density and low density lipoprotein content, composition, and size after fatty meal in normo- and hypertriglyceridemic man. J Lipid Res 1979;20:217-29.
26. Pitas RE, Mahley RW. Analysis of tissue lipoproteins. In: Converse CA, Skinner ER, eds. Lipoprotein analysis: a practical approach. New York: Oxford University Press, 1992:215-42.
27. Forte TM, Nordhausen RW. Electron microscopy of negatively stained lipoproteins. Methods Enzymol 1986;128:442-57.
28. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-5.
29. Stacewicz-Sapuntzaki M, Bowen PE, Kikendall JW, Burgess M. Simultaneous determination of serum retinol and various carotenoids: their distribution in middle-aged men and women. J Micronutr Anal 1987;3:27-45.
30. Steel RGD, Torrie JH, Dickey DA. Principles and procedures of statistics: a biometrical approach. New York: McGraw-Hill, 1997:424-5.
31. Phillips GM, Taylor PJ. Theory and applications of numerical analysis. New York: Academic Press, 1973:120-53.
32. Berr F. Characterization of chylomicron remnant clearance by retinyl palmitate label in normal humans. J Lipid Res 1992;33:915-30.
33. Gärtner C, Stahl W, Sies H. Preferential increase in chylomicron levels of the xanthophylls lutein and zeaxanthin compared to β-carotene in the human. Int J Vitam Nutr Res 1996;66:119-25.
34. Kübler W. Pharmacokinetic implications of single and repeated dosage. In: Walter P, Brubacher G, Stähelin H, eds. Elevated dosages of vitamins: benefits and hazards. Toronto, Canada: Hans Huber Publishers, 1989:25-34.
35. Romanchik JE, Morel DW. Harrison EH. Distributions of carotenoids and β-tocopherol among lipoproteins do not change when human plasma is incubated in vitro. J Nutr 1995;125:2610-7.
36. Borel P, Grolier P, Armand M, et al. Carotenoids in biological emulsions: solubility, surface-to-core distribution, and release from lipid droplets. J Lipid Res 1996;37:250-61.
37. Hoeg JM, Sviridov DD, Tennyson GE, et al. Both apolipoproteins B-48 and B-100 are synthesized and secreted by the human intestine. J Lipid Res 1990;31:1761-9.
38. Cohn JS, McNamara JR, Cohn SD, Ordovas JM, Schaefer EJ. Plasma apolipoprotein changes in the triglyceride-rich lipoprotein fraction of human subjects fed a fat-rich meal. J Lipid Res 1988;29:925-36.
39. Berr F, Kern F Jr. Plasma clearance of chylomicrons labeled with retinyl palmitate in healthy human subjects. J Lipid Res 1984;25:805-12.
40. 13C tracer approach to modeling β-carotene kinetics in humans. In: Coburn SP, Town send DW, eds. Mathematical modeling in experimental nutrition: vitamins, proteins, methods. Adv Food Nutr Res 1996;40:55-79.
41. Cornwell DG, Kruger FA, Robinson HB. Studies on the absorption of beta-carotene and the distribution of total carotenoid in human serum lipoproteins after oral administration. J Lipid Res 1962;3:65-70.
42. Johnson EJ, Russell RM. Distribution of orally administered β-carotene among lipoproteins in healthy men. Am J Clin Nutr 1992;56:128-35.
43. Schneeman BO, Kotite L, Todd KM, Havel RJ. Relationships between the responses of triglyceride-rich lipoproteins in blood plasma containing apolipoproteins B-48 and B-100 to a fat-containing meal in normolipidemic humans. Proc Natl Acad Sci U S A 1993;90:2069-73.
44. Karpe F, Bell M Björkegren J, Hamsten A. Quantification of post-prandial triglyceride-rich lipoproteins in healthy men by retinyl ester labeling and simultaneous measurement of apolipoproteins B-48 and B-100. Arterioscler Thromb Vasc Biol 1995;15:199-207.
45. van Vliet T, Schreurs WHP, van den Berg H. Intestinal β-carotene absorption and cleavage in men: response of β-carotene and retinyl esters in the triglyceride-rich lipoprotein fraction after a single oral dose of β-carotene. Am J Clin Nutr 1995;62:110-6.
46. Björkegren J, Packard CJ, Hamsten A, et al. Accumulation of large very low density lipoprotein in plasma during intravenous infusion of a chylomicron-like triglyceride emulsion reflects competition for a common lipolytic pathway. J Lipid Res 1996;37:76-86.
47. Durrington PN, Newton RS, Weinstein DB, Steinberg D. Effects of insulin and glucose on very low density lipoprotein triglyceride secretion by cultured rat hepatocytes. J Clin Invest 1982;70:63-73.
48. Sparks JD, Sparks CE. Insulin modulation of hepatic synthesis and secretion of apolipoprotein B by rat hepatocytes. J Biol Chem 1990;265:8854-62.
49. Johnson EJ, Krinsky NI, Russell RM. Serum response of all-trans β-carotene and lycopene in humans after ingestion of individual and combined doses of β-carotene and lycopene. FASEB J 1996;10:A239 (abstr).
50. van Vliet T, van Schaik F, Schreurs WHP, van den Berg H. In vitro measurement of β-carotene cleavage activity: methodological considerations and the effect of other carotenoids on β-carotene cleavage. Int J Vitam Nutr Res 1996;66:77-85.
51. Ershov YV, Bykhovsky VY, Dmitrovskii AA. Stabilization and competitive inhibition of β-carotene 15,15′-dioxygenase by carotenoids. Biochem Mol Biol Int 1994;34:755-63.